Click for best price
Drugs for Herpes Labialis Oral Herpes Market Size, Share 2023
| Market size in 2022 |
US$ 2529.2 million
|
Forecast Market size by |
US$ N/A
|
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2?3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
This report aims to provide a comprehensive presentation of the global market for Drugs for Herpes Labialis (Oral Herpes), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Herpes Labialis (Oral Herpes). This report contains market size and forecasts of Drugs for Herpes Labialis (Oral Herpes) in global, including the following market information:
The global Drugs for Herpes Labialis (Oral Herpes) market was valued at US$ 2529.2 million in 2022 and is projected to reach US$ 3485.7 million by 2029, at a CAGR of 4.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.
We surveyed the Drugs for Herpes Labialis (Oral Herpes) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Herpes Labialis (Oral Herpes) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Herpes Labialis (Oral Herpes) Market Segment Percentages, by Type, 2022 (%)
- Aciclovir
- Valacyclovir
- Famciclovir
- Docosanol
- Other
Global Drugs for Herpes Labialis (Oral Herpes) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Herpes Labialis (Oral Herpes) Market Segment Percentages, by Application, 2022 (%)
- External Use
- Oral
- Injection
Global Drugs for Herpes Labialis (Oral Herpes) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Herpes Labialis (Oral Herpes) Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Herpes Labialis (Oral Herpes) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Herpes Labialis (Oral Herpes) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GSK
- Novartis
- Teva
- Mylan
- Cadila
- Apotex
- Daewoong Pharmaceutical
- Livzon
- Luoxin
- Med shine
- Bayer (Campho Phenique)
- Blistex
- Kelun
- Hikma
- Haiwang
- Carmex
- Cipher
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Drugs for Herpes Labialis (Oral Herpes), market overview.
- Chapter 2: Global Drugs for Herpes Labialis (Oral Herpes) market size in revenue.
- Chapter 3: Detailed analysis of Drugs for Herpes Labialis (Oral Herpes) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Drugs for Herpes Labialis (Oral Herpes) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Drugs for Herpes Labialis (Oral Herpes) Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2529.2 million
|
| Forecast Market size by |
US$ N/A
|
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Herpes Labialis (Oral Herpes) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Herpes Labialis (Oral Herpes) Overall Market Size
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size: 2022 VS 2029
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Herpes Labialis (Oral Herpes) Players in Global Market
3.2 Top Global Drugs for Herpes Labialis (Oral Herpes) Companies Ranked by Revenue
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Herpes Labialis (Oral Herpes) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Herpes Labialis (Oral Herpes) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Herpes Labialis (Oral Herpes) Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Herpes Labialis (Oral Herpes) Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Herpes Labialis (Oral Herpes) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Herpes Labialis (Oral Herpes) Market Size Markets, 2022 & 2029
4.1.2 Aciclovir
4.1.3 Valacyclovir
4.1.4 Famciclovir
4.1.5 Docosanol
4.1.6 Other
4.2 By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue & Forecasts
4.2.1 By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2024-2029
4.2.3 By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Herpes Labialis (Oral Herpes) Market Size, 2022 & 2029
5.1.2 External Use
5.1.3 Oral
5.1.4 Injection
5.2 By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue & Forecasts
5.2.1 By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2024-2029
5.2.3 By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drugs for Herpes Labialis (Oral Herpes) Market Size, 2022 & 2029
6.2 By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue & Forecasts
6.2.1 By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2024-2029
6.2.3 By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2029
6.3.2 US Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.3.3 Canada Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.3.4 Mexico Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2029
6.4.2 Germany Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4.3 France Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4.4 U.K. Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4.5 Italy Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4.6 Russia Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4.7 Nordic Countries Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.4.8 Benelux Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2029
6.5.2 China Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.5.3 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.5.4 South Korea Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.5.5 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.5.6 India Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2029
6.6.2 Brazil Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.6.3 Argentina Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2029
6.7.2 Turkey Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.7.3 Israel Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
6.7.5 UAE Drugs for Herpes Labialis (Oral Herpes) Market Size, 2018-2029
7 Drugs for Herpes Labialis (Oral Herpes) Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.1.4 GSK Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.2.4 Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Teva
7.3.1 Teva Company Summary
7.3.2 Teva Business Overview
7.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.3.4 Teva Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.3.5 Teva Key News & Latest Developments
7.4 Mylan
7.4.1 Mylan Company Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.4.4 Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.4.5 Mylan Key News & Latest Developments
7.5 Cadila
7.5.1 Cadila Company Summary
7.5.2 Cadila Business Overview
7.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.5.4 Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.5.5 Cadila Key News & Latest Developments
7.6 Apotex
7.6.1 Apotex Company Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.6.4 Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.6.5 Apotex Key News & Latest Developments
7.7 Daewoong Pharmaceutical
7.7.1 Daewoong Pharmaceutical Company Summary
7.7.2 Daewoong Pharmaceutical Business Overview
7.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.7.4 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.7.5 Daewoong Pharmaceutical Key News & Latest Developments
7.8 Livzon
7.8.1 Livzon Company Summary
7.8.2 Livzon Business Overview
7.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.8.4 Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.8.5 Livzon Key News & Latest Developments
7.9 Luoxin
7.9.1 Luoxin Company Summary
7.9.2 Luoxin Business Overview
7.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.9.4 Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.9.5 Luoxin Key News & Latest Developments
7.10 Med shine
7.10.1 Med shine Company Summary
7.10.2 Med shine Business Overview
7.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.10.4 Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.10.5 Med shine Key News & Latest Developments
7.11 Bayer (Campho Phenique)
7.11.1 Bayer (Campho Phenique) Company Summary
7.11.2 Bayer (Campho Phenique) Business Overview
7.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.11.4 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.11.5 Bayer (Campho Phenique) Key News & Latest Developments
7.12 Blistex
7.12.1 Blistex Company Summary
7.12.2 Blistex Business Overview
7.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.12.4 Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.12.5 Blistex Key News & Latest Developments
7.13 Kelun
7.13.1 Kelun Company Summary
7.13.2 Kelun Business Overview
7.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.13.4 Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.13.5 Kelun Key News & Latest Developments
7.14 Hikma
7.14.1 Hikma Company Summary
7.14.2 Hikma Business Overview
7.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.14.4 Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.14.5 Hikma Key News & Latest Developments
7.15 Haiwang
7.15.1 Haiwang Company Summary
7.15.2 Haiwang Business Overview
7.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.15.4 Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.15.5 Haiwang Key News & Latest Developments
7.16 Carmex
7.16.1 Carmex Company Summary
7.16.2 Carmex Business Overview
7.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.16.4 Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.16.5 Carmex Key News & Latest Developments
7.17 Cipher
7.17.1 Cipher Company Summary
7.17.2 Cipher Business Overview
7.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Major Product Offerings
7.17.4 Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue in Global Market (2018-2023)
7.17.5 Cipher Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Herpes Labialis (Oral Herpes) Market Opportunities & Trends in Global Market
Table 2. Drugs for Herpes Labialis (Oral Herpes) Market Drivers in Global Market
Table 3. Drugs for Herpes Labialis (Oral Herpes) Market Restraints in Global Market
Table 4. Key Players of Drugs for Herpes Labialis (Oral Herpes) in Global Market
Table 5. Top Drugs for Herpes Labialis (Oral Herpes) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Herpes Labialis (Oral Herpes) Product Type
Table 9. List of Global Tier 1 Drugs for Herpes Labialis (Oral Herpes) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Herpes Labialis (Oral Herpes) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs for Herpes Labialis (Oral Herpes) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Herpes Labialis (Oral Herpes) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs for Herpes Labialis (Oral Herpes) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Herpes Labialis (Oral Herpes) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 32. GSK Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 36. Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Teva Company Summary
Table 39. Teva Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 40. Teva Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Key News & Latest Developments
Table 42. Mylan Company Summary
Table 43. Mylan Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 44. Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 45. Mylan Key News & Latest Developments
Table 46. Cadila Company Summary
Table 47. Cadila Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 48. Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 49. Cadila Key News & Latest Developments
Table 50. Apotex Company Summary
Table 51. Apotex Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 52. Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 53. Apotex Key News & Latest Developments
Table 54. Daewoong Pharmaceutical Company Summary
Table 55. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 56. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 57. Daewoong Pharmaceutical Key News & Latest Developments
Table 58. Livzon Company Summary
Table 59. Livzon Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 60. Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 61. Livzon Key News & Latest Developments
Table 62. Luoxin Company Summary
Table 63. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 64. Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 65. Luoxin Key News & Latest Developments
Table 66. Med shine Company Summary
Table 67. Med shine Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 68. Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 69. Med shine Key News & Latest Developments
Table 70. Bayer (Campho Phenique) Company Summary
Table 71. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 72. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 73. Bayer (Campho Phenique) Key News & Latest Developments
Table 74. Blistex Company Summary
Table 75. Blistex Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 76. Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 77. Blistex Key News & Latest Developments
Table 78. Kelun Company Summary
Table 79. Kelun Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 80. Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 81. Kelun Key News & Latest Developments
Table 82. Hikma Company Summary
Table 83. Hikma Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 84. Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 85. Hikma Key News & Latest Developments
Table 86. Haiwang Company Summary
Table 87. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 88. Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 89. Haiwang Key News & Latest Developments
Table 90. Carmex Company Summary
Table 91. Carmex Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 92. Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 93. Carmex Key News & Latest Developments
Table 94. Cipher Company Summary
Table 95. Cipher Drugs for Herpes Labialis (Oral Herpes) Product Offerings
Table 96. Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue (US$, Mn) & (2018-2023)
Table 97. Cipher Key News & Latest Developments
List of Figures
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Segment by Type in 2022
Figure 2. Drugs for Herpes Labialis (Oral Herpes) Segment by Application in 2022
Figure 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Herpes Labialis (Oral Herpes) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Herpes Labialis (Oral Herpes) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2022
Figure 8. By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 16. US Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 20. Germany Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 28. China Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs for Herpes Labialis (Oral Herpes) Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
